Crescent Capital BDC, Inc. (CCAP) - 2020 Annual Report Summary
Business Context and Reporting Period
Crescent Capital BDC, Inc. (CCAP) is a specialty finance company and Business Development Company (BDC) focused on lending to U.S. middle-market companies. The reporting period covers the fiscal year ended December 31, 2020. During this period, the Company completed the acquisition of Alcentra Capital Corporation (the "Alcentra Acquisition") on January 31, 2020, significantly expanding its portfolio. The Company is managed by Crescent Cap Advisors, LLC, and elected to be taxed as a Regulated Investment Company (RIC).
Key Financial Metrics
| Metric | 2020 Value | 2019 Value |
|---|---|---|
| Total Investment Income | $77.1 million | $53.5 million |
| Net Investment Income | $49.9 million | $31.7 million |
| Net Realized Gains (Losses) | ($15.3 million) | ($7.2 million) |
| Net Unrealized Appreciation (Depreciation) | $24.1 million | $5.0 million |
| Net Increase in Net Assets from Operations | $54.7 million | $29.3 million |
| Total Portfolio Investments (Fair Value) | $1,034.0 million | $726.5 million |
| Net Asset Value (NAV) per Share | $19.88 | $19.50 |
| Dividends Declared per Share | $1.64 | $1.64 |
| Weighted Average Yield on Income Producing Securities | 8.0% | 8.1% |
| Asset Coverage Ratio | 217% | 225% |
| Total Debt Outstanding (Carrying Value) | $476.5 million | $325.4 million |
| Cash and Cash Equivalents | $14.8 million | $13.4 million |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments increased by approximately 42% to $1.034 billion, driven primarily by the Alcentra Acquisition (which added $195.7 million in assets at cost) and organic net deployment of $93.4 million.
- Revenue Increase: Total investment income rose 44% to $77.1 million, with interest income increasing from $47.7 million to $71.1 million due to the larger portfolio size.
- Expense Management: While gross expenses increased to $40.0 million (from $30.9 million), the Company benefited from significant fee waivers. The Adviser waived $4.7 million in management fees and $8.6 million in incentive fees, resulting in net expenses of $26.7 million.
- Realized Losses: Net realized losses increased to $15.3 million (from $7.2 million), including a $3.8 million realized loss on the Alcentra Acquisition.
- Unrealized Gains: Net unrealized appreciation improved significantly to $24.1 million (from $5.0 million), largely due to recoveries in portfolio values.
- Debt Financing: Total debt increased to $476.5 million to support portfolio growth. The Company issued $50.0 million in senior unsecured notes in 2020.
Guidance, Outlook, and Risks
Management Commentary & Outlook: The Company continues to focus on maximizing total return through debt and related equity investments in middle-market companies. Management noted that the Alcentra Acquisition was successfully integrated. The Company maintains a dividend policy of distributing quarterly dividends, with $0.41 per share declared in each quarter of 2020. The Adviser has voluntarily waived incentive fees to the extent net investment income falls short of the declared dividend, a policy extended through December 31, 2022.
Key Risks and Contingencies:
- COVID-19 Impact: The pandemic has caused global economic disruption, potentially increasing defaults and reducing the value of collateral. Management is monitoring liquidity and covenant compliance closely.
- LIBOR Transition: The discontinuation of LIBOR after 2021 poses risks to the valuation of LIBOR-indexed securities and loans in the portfolio. The Company may need to renegotiate credit agreements.
- Leverage: The Company utilizes leverage to enhance returns, which magnifies potential losses. Asset coverage ratios must be maintained at 150% or higher.
- Valuation Uncertainty: A significant portion of the portfolio consists of private, illiquid securities valued in good faith by the Board, which may differ from realized values.
- Conflicts of Interest: The Investment Adviser and its affiliates manage other funds, creating potential conflicts in the allocation of investment opportunities.
Investor Verification Checklist
- Verify the sustainability of the dividend payout ratio given the increase in realized losses and the reliance on fee waivers to maintain net investment income.
- Review the specific terms of the Alcentra Acquisition integration and the realization of anticipated synergies.
- Assess the Company's exposure to LIBOR-indexed assets and the progress of transition plans to alternative reference rates (e.g., SOFR).
- Monitor the asset coverage ratio and debt maturity schedule to ensure compliance with 1940 Act requirements and credit facility covenants.
- Evaluate the concentration of the portfolio in specific sectors (e.g., Healthcare, Software & Services) and the impact of sector-specific economic downturns.
- Confirm the status of the $80.8 million in unfunded commitments to portfolio companies and the liquidity required to meet them.